294
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Prevalence, clinical characteristics and outcomes of hypoxic hepatitis in critically ill patients

, , , , &
Pages 311-318 | Received 26 Aug 2021, Accepted 06 Nov 2021, Published online: 30 Nov 2021
 

Abstract

Background

Hypoxic hepatitis (HH) is an important clinical entity in patients in the intensive care unit (ICU). The aims of the study were to assess the etiology, clinical characteristics and outcomes of HH in the ICU of a tertiary hospital. Secondary aim was to analyze the effects of concomitant ischemia in other organs than the liver.

Methods

All patients with HH, 2011–2018, in a university hospital ICU were included. Data were collected on etiology, relevant clinical data and outcome. HH was defined by an increase in aminotransferases ≥10 times the upper limit of normal within 48 h from a clinical event of cardiac, circulatory or respiratory failure. Other causes of liver cell necrosis were excluded.

Results

Of 9,931 patients hospitalized in the ICU, 159 (1.6%) fulfilled criteria for HH. In-hospital mortality occurred in 85 (53%) and 60 (38%) survived one year. Median ICU stay was five days (interquartile range (IQR) 3–10) and median hospital stay 16 days (IQR 7–32). Shock (48%), cardiac arrest (25%) and hypoxia (13%) were the most common causes of HH. Acute kidney injury (81%), rhabdomyolysis (50%), intestinal ischemia (6%) and ischemic pancreatitis (3%) occurred concomitantly. Age (odds ratio (OR) 1.05 (95% CI 1.02–1.09)), serum lactate (OR 2.61 (95% CI 1.23–5.50)) and lactate dehydrogenase (OR 1.14 (95% CI 1.02–1.27)) were predictors of mortality.

Conclusions

Hypoxic hepatitis was related to shock in approximately 50% of cases and associated with high in-hospital mortality. HH was commonly associated with ischemia in other organs. In-hospital mortality was associated with age, lactate and LD.

Acknowledgements

The authors thank Ingibjörg Richter and Helga H. Bjarnadóttir dearly for assisting with data acquisition.

Disclosure statement

The author(s) have no conflict of interest to declare.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.